Actuate Therapeutics Inc. (ACTU)
NASDAQ: ACTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ACTU stock chart
Technical analysisKey statistics
All statistics- Market cap
- $17.39M
- EPS (TTM)
- -$0.77
- Dividend yield
- None
- 52-week range
- 0.604 – 8.49
- Day range
- 0.615 – 0.7242
- Volume / Avg
- 636.16K / 387.90K
- Beta
- —
- Shares outstanding
- 24.01M
- Next earnings
- Nov 12, 2026
52-week range
ACTU stock today
Actuate Therapeutics (ACTU) closed at $0.7242 on Oct 7, down 10.77% (-$0.0874), versus the S&P 500's 0.22% decline. Shares are 91.5% below their 52-week high of $8.49, set on Oct 10, 2025 and 19.9% above the 52-week low of $0.604, near the bottom of the past year's range. ACTU is down 88.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 89.7%.
Actuate Therapeutics has posted a net loss over the last twelve months (EPS of -$0.77), so its P/E ratio is not meaningful. Actuate Therapeutics's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Actuate Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 12, 2026
Actuate Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MRKRMarker Therapeutics Inc. | 1.04 | +2.97% | $17.34M | vs ACTU |
| NCELNewcelX Ltd. | 3.04 | +2.51% | $17.53M | vs ACTU |
| PTNPalatin Technologies Inc. | 9.52 | +1.17% | $16.95M | vs ACTU |
| RADXRadiopharm Theranostics Limited ADR | 1.15 | -2.54% | $16.78M | vs ACTU |
| RKTORocket One Inc. | 0.67 | -4.48% | $16.68M | vs ACTU |
| LPCNLipocine Inc. | 2.20 | +4.76% | $18.14M | vs ACTU |
| NEUPNeuphoria Therapeutics Inc. | 3.42 | -0.29% | $18.51M | vs ACTU |
| ALLRAllarity Therapeutics Inc. | 0.984 | -0.13% | $15.66M | vs ACTU |
Indexes, lists and sector
Actuate Therapeutics stock FAQ
What is Actuate Therapeutics's stock price today?
ACTU last traded at $0.7242 as of Oct 7, 4:00 PM EDT, down 10.77% on the day. Prices are delayed at least 15 minutes.
When is Actuate Therapeutics's next earnings date?
Actuate Therapeutics is expected to report earnings on Thursday, November 12, 2026.
What is the ACTU 52-week high?
The 52-week high for ACTU is $8.49 and the 52-week low is $0.604. The stock is currently 91.5% below its high.